YP

Yogesh Pandurang Bhakare

Active Director Director DIN 10890590
DIN 10890590 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogesh Pandurang Bhakare

Data last updated:

Yogesh Pandurang Bhakare is a Director at Acopt Pharmaceutical Private Limited (since 2024).

DIN 10890590
Primary Designation Director
First Appointment 29 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acopt Pharmaceutical Private Limited U46497MH2024PTC437270
Director29 Dec 20242024Active

Board colleagues of Yogesh Pandurang Bhakare

NameDINCompanyDesignation
Rahul Dadasaheb Wagh10890591Acopt Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Acopt Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Yogesh Pandurang Bhakare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Pandurang Bhakare

Yogesh Pandurang Bhakare currently holds 1 directorship: Acopt Pharmaceutical Private Limited (Director, since 29 Dec 2024).

Yogesh Pandurang Bhakare was first appointed on 29 Dec 2024 as Director at Acopt Pharmaceutical Private Limited.

The current boards of Yogesh Pandurang Bhakare's companies include Rahul Dadasaheb Wagh (Acopt Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available